← FDA Drug Approvals (Drugs@FDA)

RITONAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2015-01-15

Drug application

FDA Application #

ANDA202573

Application type

Abbreviated New Drug Application (Generic)

Brand name

RITONAVIR

Generic name

RITONAVIR 100 MG

Active ingredients

RITONAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2015-01-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown